Inventor · disambiguated record
Steven Staben
Also filed as: STABEN STEVEN · STABEN STEVEN T · STABEN STEVEN THOMAS
38 granted patents·15 pending applications·352 citations·filing 2007–2025
97Inventor score
Top patents by PatentIndex Score
53 records- 0198US8785626B2Benzoxazepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2013·Granted Jul 22, 2014·54 cites·4 claims
- 0297US8343955B2Benzoxazepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2012·Granted Jan 1, 2013·39 cites·31 claims
- 0396US9650393B2Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2016·Granted May 16, 2017·20 cites·23 claims
- 0496US8673952B2Benzoxepin PI3K inhibitor compounds and methods of useBLAQUIERE NICOLE·Filed 2012·Granted Mar 18, 2014·42 cites·22 claims
- 0596US8242104B2Benzoxazepin P13K inhibitor compounds and methods of useBLAQUIERE NICOLE·Filed 2010·Granted Aug 14, 2012·53 cites·33 claims
- 0695US8586574B2Benzoxazepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2012·Granted Nov 19, 2013·19 cites·2 claims
- 0795US8263633B2Benzoxepin PI3K inhibitor compounds and methods of useBLAQUIERE NICOLE·Filed 2010·Granted Sep 11, 2012·29 cites·4 claims
- 0894US11242344B2(4-hydroxypyrrolidin-2-yl)-heterocyclic compounds and methods of use thereofGENENTECH INC·Filed 2020·Granted Feb 8, 2022·5 cites·29 claims
- 0994US10851091B2Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2018·Granted Dec 1, 2020·5 cites·3 claims
- 1093US11760753B2Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2020·Granted Sep 19, 2023·2 cites·17 claims
- 1192US10112932B2Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2017·Granted Oct 30, 2018·8 cites·9 claims
- 1292US7888352B2Phosphoinositide 3-kinase inhibitor compounds and methods of usePIRAMED LTD·Filed 2007·Granted Feb 15, 2011·23 cites·21 claims
- 1389US2025197386A1Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2024·Application pending·0 cites
- 1488US12006331B2Therapeutic compounds and methodsGENENTECH INC·Filed 2022·Granted Jun 11, 2024·1 cites·17 claims
- 1588US9605005B2Alkynyl alcohols and methods of useGENENTECH INC·Filed 2016·Granted Mar 28, 2017·5 cites·4 claims
- 1688US7928248B2Benzopyran and benzoxepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2009·Granted Apr 19, 2011·10 cites·14 claims
- 1788US2025326745A1Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2025·Application pending·0 cites
- 1886US2024199594A1Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2023·Application pending·0 cites
- 1985US9546178B2Benzoxazepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2015·Granted Jan 17, 2017·3 cites·8 claims
- 2085US8399690B24,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulene compoundsDO STEVEN·Filed 2011·Granted Mar 19, 2013·8 cites·9 claims
- 2182US8383620B2Phosphoinositide 3-kinase inhibitor compounds and methods of useGENENTECH INC·Filed 2010·Granted Feb 26, 2013·5 cites·20 claims
- 2280US9643980B2Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2016·Granted May 9, 2017·3 cites·21 claims
- 2380US8952043B2Benzoxepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2014·Granted Feb 10, 2015·3 cites·21 claims
- 2479US11666581B2PROTAC antibody conjugates and methods of useGENENTECH INC·Filed 2018·Granted Jun 6, 2023·2 cites·22 claims
- 2579US8846762B2Benzopyran and benzoxepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2013·Granted Sep 30, 2014·3 cites·13 claims
- 2678US9670228B2Benzoxazepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2016·Granted Jun 6, 2017·1 cites·4 claims
- 2777US8653098B2Pyrazolopyridine PI3K inhibitor compounds and methods of useDOTSON JENNAFER·Filed 2009·Granted Feb 18, 2014·3 cites·23 claims
- 2876US12459957B2Therapeutic compounds and methodsGENENTECH INC·Filed 2024·Granted Nov 4, 2025·0 cites·20 claims
- 2975US2025115618A1Sulfonimidamide compounds as inhibitors of interleukin-1 activityGENENTECH INC·Filed 2024·Application pending·0 cites
- 3074US9487533B2Phosphoinositide 3-kinase inhibitor compounds and methods of useCASTANEDO GEORGETTE·Filed 2007·Granted Nov 8, 2016·2 cites·5 claims
- 3174US2025084096A1Tert-butyl (s)-2-(4-(phenyl)-6h-thieno[3, 2-f][1, 2, 4]triazolo[4, 3-a] [1,4]diazepin-6-yl) acetate derivatives and related compounds as bromodomain brd4 inhibitors for treating cancerGENENTECH INC·Filed 2024·Application pending·0 cites
- 3272US9034866B2Tricyclic compounds and methods of use thereforGENENTECH INC·Filed 2013·Granted May 19, 2015·2 cites·29 claims
- 3370US10065970B2Tricyclic PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2016·Granted Sep 4, 2018·1 cites·18 claims
- 3469US2023330102A1Protac antibody conjugates and methods of useGENENTECH INC·Filed 2023·Application pending·0 cites
- 3566US9175009B2Benzoxepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2014·Granted Nov 3, 2015·0 cites·5 claims
- 3665US9198918B2Benzoxazepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2014·Granted Dec 1, 2015·0 cites·12 claims
- 3763US12152040B2Tert-butyl (s)-2-(4-(phenyl)-6H-thieno[3, 2-f][1, 2, 4]triazolo[4, 3-a] [1,4]diazepin-6-yl) acetate derivatives and related compounds as bromodomain BRD4 inhibitors for treating cancerGENENTECH INC·Filed 2021·Granted Nov 26, 2024·0 cites·31 claims
- 3863US2017210733A1Benzoxazepin oxazolidinone compounds and methods of useGENENTECH INC·Filed 2017·Application pending·0 cites
- 3961US12234245B2Sulfonimidamide compounds as inhibitors of interleukin-1 activityGENENTECH INC·Filed 2021·Granted Feb 25, 2025·0 cites·19 claims
- 4061US9309265B2Benzopyran and benzoxepin PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2014·Granted Apr 12, 2016·0 cites·12 claims
- 4160US9090628B2Benzoxazepin compounds selective for PI3K P110 delta and methods of useHEFFRON TIMOTHY·Filed 2012·Granted Jul 28, 2015·1 cites·6 claims
- 4260US8993563B2Phosphoinositide 3-kinase inhibitor compounds and methods of useGENENTECH INC·Filed 2013·Granted Mar 31, 2015·0 cites·6 claims
- 4360US2023159555A1Sulfonimidamide compounds as nlrp3 modulatorsGENENTECH INC·Filed 2022·Application pending·0 cites
- 4458US2016096850A9Alkynyl alcohols and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 4558US2015057260A1Alkynyl alcohols and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 4654US11560391B2Sulfonylurea compounds as inhibitors of interleukin-1 activityGENENTECH INC·Filed 2021·Granted Jan 24, 2023·0 cites·21 claims
- 4752US2017210724A1Alkynyl alcohols and methods of useGENENTECH INC·Filed 2017·Application pending·0 cites
- 4852US2017145034A1Alkynyl alcohols and methods of useGENENTECH INC·Filed 2017·Application pending·0 cites
- 4952US2015038460A16,5-Heterocyclic Propargylic Alcohol Compounds and Uses ThereforGENENTECH INC·Filed 2014·Application pending·0 cites
- 5050US10435414B2Tricyclic PI3K inhibitor compounds and methods of useGENENTECH INC·Filed 2018·Granted Oct 8, 2019·0 cites·23 claims
Showing the top 50 of 53 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →